Immune involvement in schizophrenia and autism: Etiology, pathology and animal models

Behavioural Brain Research

Volumn 204, Issue 2, 2009, Pages 313-321

  Patterson, Paul H ^a  

^a CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

IL 10; IL 6; Influenza; LPS; Maternal immune activation; Poly(I:C)

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIINFLAMMATORY AGENT; CYTOKINE; INTERLEUKIN 10; NEUROLEPTIC AGENT; PIOGLITAZONE;

ANTIGEN ANTIBODY REACTION; ARTICLE; AUTISM; AUTOIMMUNITY; BACTERIAL INFECTION; BEHAVIOR DISORDER; BRAIN DEVELOPMENT; DEVELOPMENTAL DISORDER; DISEASE ASSOCIATION; DISEASE COURSE; DRUG SYNTHESIS; ENVIRONMENTAL FACTOR; FETUS DEVELOPMENT; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; IMMUNOPATHOGENESIS; IMMUNOPATHOLOGY; IMMUNOREACTIVITY; IMMUNOSTIMULATION; INFLUENZA; MATERNAL DISEASE; MENTAL STRESS; NEUROPATHY; NONHUMAN; PATHOPHYSIOLOGY; PREPULSE INHIBITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PYRAMIDAL NERVE CELL; RESPIRATORY TRACT INFECTION; RISK ASSESSMENT; RISK FACTOR; SCHIZOPHRENIA; SYMPTOM; SYMPTOMATOLOGY; VIRUS INFECTION;

ANIMALS; AUTISTIC DISORDER; BRAIN; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; INFLAMMATION MEDIATORS; INFLUENZA, HUMAN; MICE; PERIODONTAL DISEASES; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL EXPOSURE DELAYED EFFECTS; RABBITS; RATS; RISK FACTORS; SCHIZOPHRENIA;

EID: 67749114055     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2008.12.016     Document Type: Article

References (123)

1. Muller N., and Schwarz M. Schizophrenia as an inflammation-mediated dysbalance of glutamatergic neurotransmission. Neurotox Res 10 (2006) 131-148
2. Pardo C.A., Vargas D.L., and Zimmerman A.W. Immunity, neuroglia and neuroinflammation in autism. Intl Rev Psychiat 17 (2005) 485-495
3. Sperner-Unterweger B. Immunological aetiology of major psychiatric disorders. Evidence and therapeutic implications. Drugs 65 (2006) 1493-1520
4. Strous R.D., and Shoenfeld Y. Schizophrenia, autoimmunity and immune system dysregulation: a comprehensive model updated and revisited. J Autoimmun 27 (2006) 71-80
5. Knight J.G., Menkes D.B., Highton J., and Adams D.D. Rationale for a trial of immunosuppressive therapy in acute schizophrenia. Mol Psychiatry 12 (2007) 424-431
6. Potvin S., Stip E., Sepehry A.A., Gendron A., Bah R., and Kouassi E. Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review. Biol Psychiatry 63 (2007) 801-808
7. Vargas D.L., Nascimbene C., Krishnan C., Zimmerman A.W., and Pardo C.A. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol 57 (2005) 67-81
8. Arion D., Travis U.T., Lewis D.A., Levitt P., and Mirnics K. Molecular evidence for increased expression of genes related to immune and chaperone function in the prefrontal cortex in schizophrenia. Biol Psychiatry 62 (2007) 711-721
9. Chez M.G., Dowling T., Patel P.B., Khanna P., and Kominsky M. Elevation of tumor necrosis factor-alpha in cerebrospinal fluid of autistic children. Pediatr Neurol 36 (2007) 361-365
10. Garbett KA, Ebert P, Lintas C, Mirnics K, Persico AM. Immune transcript disturbances in temporal cortex of autistic brains. Program No. 61.15. Neuroscience Meeting Planner. San Diego, CA: Soc Neurosci; 2007 [online].
11. Morgan JT, Chana G, Buckwalter J, Courchsne E, Everall IP. Microglial activation in a 3-year old autistic brain. Program No. 172.12. Neuroscience Meeting Planner. San Diego, CA: Soc Neurosci; 2007 [online].
12. Saetre P., Emilsson L., Axelson E., Kreuger J., Lindholm E., and Jazin E. Inflammation-related genes up-regulated in schizophrenia brains. BMC Psychiat 7 (2007) 46
13. Soderlund J, Karlsson H, Schroder J, Samuelsson M, Erhardt S, Nordin C, Karlsson H, Engberg G. Evidence for activated immunological responses in patients with schizophrenia during their first episode of psychosis. Program No. 656.21. Neuroscience Meeting Planner. Washington DC: Soc Neurosci; 2008 [online].
14. Penner J.D., and Brown A.S. Prenatal infectious and nutritional factors and risk of adult schizophrenia. Expert Rev Neurotherapeut 7 (2007) 797-805
15. Byrne M., Agerbo E., Bennedsen B., Eaton W.W., and Mortensen P.B. Obstetric conditions and risk of first admission with schizophrenia: a Danish national register based study. Schiz Res 97 (2007) 51-59
16. Brown A.S., Begg M.D., Gravenstein S., Schaefer C.A., Wyatt R.J., Bresnahan M., et al. Serologic evidence of prenatal influenza in the etiology of schizophrenia. Arch Gen Psychiatry 61 (2004) 774-780
17. Brown A.S., Hooton J., Schaefer C.A., Zhang H., Petkova E., Babulas V., et al. Elevated maternal interleukin-8 levels and risk of schizophrenia in adult offspring. Am J Psychiatry 161 (2004) 889-895
18. Brown AS, Deicken RF, Vinogradov S, Kremen WS, Poole JH, Penner JD, Kochetkova A, Kern D, Schaefer CA. Prenatal infection and cavum septum pellucidum in adult schizophrenia. Schiz Res, in press.
19. Patterson P.H. Maternal effects on schizophrenia risk. Science 318 (2007) 576-577
20. Sorensen HJ, Mortensen EL, Reinisch JM, Mednick SA. Association between prenatal exposure to bacterial infection and risk of schizophrenia. Schizhophr Bull, in press.
21. Ciaranello A.L., and Ciaranello R.D. The neurobiology of infantile autism. Annu Rev Neurosci 18 (1995) 101-128
22. Hyman S.L., Arndt T.L., and Rodier P.M. Environmental agents and autism: once and future associations. Intern Rev Res Ment Retard 30 (2006) 171-194
23. Moy S.S., and Nadler J.J. Advances in behavioral genetics: mouse models of autism. Mol Psychiatry 13 (2008) 4-26
24. Jonakait G.M. The effects of maternal inflammation on neuronal development: possible mechanisms. Int J Dev Neurosci 25 (2007) 415-425
25. Patterson P.H. Maternal infection: window on neuroimmune interactions in fetal brain development and mental illness. Curr Opin Neurobiol 12 (2002) 115-118
26. Gekas D., Dieterlen-Lievre F., Orkin S.H., and Mikkola H.K.A. The placenta is a niche for hematopoietic stem cells. Dev Cell 8 (2005) 365-375
27. Anderson G.M., Jacobs-Stannard A., Chawarska K., Volkmar F.R., and Kliman H.J. Placental trophoblast inclusions in autism spectrum disorder. Biol Psychiatry 61 (2007) 487-491
28. Fatemi S.H., Emamian E.S., Kist D., Sidwell R.W., Nakajima K., Akhter P., et al. Defective corticogenesis and reduction in reelin immunoreactivity in cortex and hippocampus of prenatally neonatal mice. Mol Psychiatry 4 (1999) 145-154
29. Fatemi S.H., Cuadra A.E., El-Fakahany E.E., Sidwel R.W., and Thuras P. Prenatal viral infection causes alterations in nNOS expression in developing mouse brains. Neuroreport 11 (2000) 1493-1496
30. Fatemi S.H., Emamian E.S., Sidwell R.W., Kist D.A., Stary J.M., Earle J.A., et al. Human influenza viral infection in utero alters glial fibrillary acidic protein immunoreactivity in the developing brains of neonatal mice. Mol Psychiatry 7 (2002) 633-640
31. Shi L., Smith S.E.P., Malkova N., Tse D., and Patterson P.H. Activation of the maternal immune response alters cerebellar development in the offspring. Brain Behav Immun 23 (2008) 116-123
32. Palmen S.J., van Engeland H., Hof P.R., and Schmitz C. Neuropathological findings in autism. Brain 127 (2004) 2572-2583
33. Amaral D.G., Schumann C.M., and Nordahl C.W. Neuroanatomy of autism. Trends Neurosci 31 (2008) 137-145
34. Kamiya A., Kubo K.-I., Tomoda T., Takaki M., Youn R., Ozeki Y., et al. A schizophrenia-associated mutation of DISC1 perturbs cerebral cortex development. Nature Cell Biol 7 (2005) 1167-1178
35. Shi L., Fatemi S.H., Sidwell R.W., and Patterson P.H. A mouse model of mental illness: maternal influenza infection causes behavioral and pharmacological abnormalities in the offspring. J Neurosci 23 (2003) 297-302
36. Fatemi S.H., Pearce D.A., Brooks A.I., and Sidwell R.W. Prenatal viral infection in mouse causes differential expression of genes in brains of mouse progeny: a potential animal model for schizophrenia and autism. Synapse 57 (2005) 91-99
37. Fatemi SH, Reutiman TJ, Folsom TD, Huang H, Oishi K, Mori S, Smee DF, Pearce DA, Winter C, Sohr R, Juckel G. Maternal infection leads to abnormal gene regulation and brain atrophy in mouse offspring: implications for genesis of neurodevelopmental disorders. Schiz Res, in press.
38. Winter C, Reutiman TJ, Folsom TD, Sohr R, Olf RJ, Juckel G, Fatemi SH. Dopamine and serotonin levels following prenatal viral infection in mouse - implications for psychiatric disorders such as schizophrenia and autism. Europ Neuropsychopharmacol, in press.
39. Bobetsis Y.A., Barros S.P., and Offenbacher S. Exploring the relationship between periodontal disease and pregnancy complications. J Am Dent Assoc 137 Suppl (2006) 7S-13S
40. Han Y.W., Redline R.W., Li M., Yin L., Hill G.B., and McCormick T.S. Fusobacterium nucleatum induces premature and term stillbirths in pregnant mice: implication of oral bacteria in preterm birth. Infect Immun 72 (2004) 2272-2279
41. Lin D., Smith M.A., Elter J., Champagne C., Downey C.L., Beck J., and Offenbacher S. Porphyromonas gingivalis infection in pregnant mice is associated with placental dissemination, an increase in the placental Th1/Th2 cytokine ratio, and fetal growth restriction. Infect Immun 71 (2003) 5163-5168
42. Smith S.E.P., Li J., Garbett K., Mirnics K., and Patterson P.H. Maternal immune activation alters fetal brain development through interleukin-6. J Neurosci 27 (2007) 10695-10702
43. Zuckerman L., Rehavi M., Nachman R., and Weiner I. Immune activation during pregnancy in rats leads to a postpubertal emergence of disrupted latent inhibition, dopaminergic hyperfunction, and altered limbic morphology in the offspring: a novel neurodevelopmental model of schizophrenia. Neuropsychopharmacology 28 (2003) 1778-1789
44. Fortier M.E., Luheshi G.N., and Boksa P. Maternal exposure to bacterial endotoxin during pregnancy enhances amphetamine-induced locomotion and startle responses in adult rat offspring. J Psychiatr Res 38 (2004) 335-345
45. Zuckerman L., and Weiner I. Maternal immune activation leads to behavioral and pharmacological changes in the adult offspring. J Psychiatr Res 39 (2005) 311-323
46. Meyer U., Feldon J., Schedlowski M., and Yee B.K. Towards an immuno-precipitated neurodevelopmental animal model of schizophrenia. Neurosci Biobehav Rev 29 (2005) 913-947
47. Meyer U., Nyffeler M., Engler A., Urwyler A., Schedlowski M., Knuesel I., et al. The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology. J Neurosci 26 (2006) 4752-4762
48. Ozawa K., Hashimoto K., Kishimoto T., Shimizu E., Ishikura H., and Iyo M. Immune activation during pregnancy in mice leads to dopaminergic hyperfunction and cognitive impairment in the offspring: a neurodevelopmental animal model of schizophrenia. Biol Psychiatry 59 (2006) 546-554
49. Smith SE, Ito H, Schuman EM, Patterson PH. Maternal immune activation alters hippocampal-dependent behavior and cellular responses to dopamine in the hippocampus of adult offspring. Program No. 842.1. Neuroscience Meeting Planner. Washington DC: Soc Neurosci; 2008 [online].
50. Wolff A.R., Cheyne K.R., and Bilkey D.K. Hippocampal dysfunction in an animal model of schizophrenia. Int Brain Res Org (2007) [Abstr SYM-25-34]
51. Wolff A.R., and Bilkey D.K. Immune activation during mid-gestation disrupts sensorimotor gating in rat offspring. Behav Brain Res 190 (2008) 156-159
52. A receptor immunoreactivity in the adult offspring: Implications for schizophrenia. Neurosci 143 (2006) 51-62
53. Makinodan M., Tatsumi K., Manabe T., Yamauchi T., Makinodan E., Matsuyoshi H., et al. Maternal immune activation in mice delays myelination and axonal development in the hippocampus of the offspring. J Neurosci Res 86 (2008) 2190-2200
54. Piontkewitz Y., Weiner I., and Assaf Y. Post-pubertal emergence of schizophrenia-like abnormalities following prenatal maternal immune system activation and their prevention: modeling the disorder and its prodrome. Int Brain Res Org (2007) 25-33 [Abstr SYM]
55. Meyer U., Nyffeler M., Yee B.K., Knuesel I., and Feldon J. Adult brain and behavioral pathological markers of prenatal immune challenge during early/middle and late fetal development in mice. Brain Behav Immun 22 (2008) 469-486
56. Meyer U., Nyffeler M., Schwendener S., Knuesel I., Yee B.K., and Feldon J. Relative prenatal maternal contributions to schizophrenia-related neurochemical dysfunction after in utero immune challenge. Neuropschopharmacology 33 (2008) 441-456
57. Meyer U, Spoerri E, Yee BK, Schwarz J, Feldon J. Evaluating early preventative antipsychotic and antidepressant drug treatment in an infection-based neurodevelopmental mouse model of schizophrenia. Schizophr Bull, in press.
58. Pollmacher T., Haack M., Schuld A., Kraus T., and Hinze-Selch D. Effects of antipsychotic drugs on cytokine networks. J Psychiatr Res 34 (2000) 369-382
59. Drzyzga L., Obuchowicz E., Marcinowska A., and Herman Z.S. Cytokines in schizophrenia and the effects of antipsychotic drugs. Brain Behav Immun 20 (2006) 532-545
60. Meyer U., Yee B.K., and Feldon J. The neurodevelopmental impact of prenatal infections at different times of pregnancy: the earlier the worse?. Neuroscientist 13 (2007) 241-256
61. Patterson PH, Xu W, Smith SEP, Deverman BE. Maternal immune activation, cytokines and autism. In: Zimmerman AW, editor. Autism: current theories and evidence. Totowa, NJ: Humana Press, in press.
62. Smith SEP, Patterson PH. Alteration of neurodevelopment and behavior by maternal immune activation. In: A. Siegel, S.S. Zalcman, editors. The neuroimmunological basis of behavior and mental disorders, Springer, Norwell, MA, in press.
63. Borrell J., Vela J.M., Arevalo-Martin A., Molina-Holgado E., and Guaza C. Prenatal immune challenge disrupts sensorimotor gating in adult rats. Implications for the etiopathogenesis of schizophrenia. Neuropsychopharmacology 26 (2002) 204-215
64. 11C-(R)-PK11195 and small animal PET. J Nucl Med 48 (2007) 946-954
65. Fatemi S.H., Araghi-Niknam M., Laurence J.A., Stary J.M., and Lee S. Glial fibrillary acidic protein and glutamic acid decarboxylase 65 and 67 kDa proteins are increased in brains of neonatal BALB/c mice following viral infection in utero. Schiz Res 69 (2004) 121-123
66. Romero E., Carine A., Molina-Holgado E., Castellano B., Guaza C., and Borrell J. Neurobehavioral and immunological consequences of prenatal immune challenge in rats. Influence of antipsychotics. Neuropsychopharmacology 32 (2007) 1791-1804
67. Wang X., Rousset C.I., Hagberg H., and Mallard C. Lipopolysaccharide-induced inflammation and perinatal brain injury. Semin Fetal Neonatal Med 11 (2006) 343-353
68. Pearce B. Modeling the role of infections in the etiology of mental illness. Clin Neurosci Res 3 (2003) 271-282
69. Nawa H., and Takei N. Recent progress in animal modeling of immune inflammatory processes in schizophrenia: implication of specific cytokines. Neurosci Res 56 (2006) 2-13
70. Patterson P.H. Modeling features of autism in animals. In: Moldin S.O., and Rubenstein J.L.R. (Eds). Understanding autism: from basic neuroscience to treatment (2006), Taylor & Francis, Boca Raton, FL 277-302
71. Elovitz M.A., Mrinalini C., and Sammel M.D. Elucidating the early signal transduction pathways leading to fetal brain injury in preterm birth. Pediatr Res 59 (2006) 50-55
72. Meyer U, Feldon J, Yee BK. A review of the fetal brain cytokine imbalance hypothesis of schizophrenia. Schizophr Bull, in press.
73. Gilmore J.H., Jarskog L.F., and Vadlamudi S. Maternal poly I:C exposure during pregnancy regulates TNF alpha, BDNF, and NGF expression in neonatal brain and the maternal-fetal unit of the rat. J Neuroimmunol 159 (2005) 106-112
74. Silver R.M., Lohner W.S., Daynes R.A., Mitchell M.D., and Branch D.W. Lipopolysaccharide-induced fetal death: the role of tumor-necrosis factor alpha. Biol Reprod 50 (1994) 1108-1112
75. Xu D.X., Chen Y.H., Wang H., Zhao L., Wang J.P., and Wei W. Tumor necrosis factor alpha partially contributes to lipopolysaccharide-induced intra-uterine fetal growth restriction and skeletal development retardation in mice. Toxicol Lett 163 (2006) 20-29
76. Wang X., Hagberg H., Mallard C., et al. Disruption of interleukin-18, but not interleukin-1, increases vulnerability to preterm delivery and fetal mortality after intrauterine inflammation. Am J Pathol 169 (2006) 967-976
77. Pang Y., Rodts-Palenik S., Cai Z., Bennett W.A., and Rhodes P.G. Suppression of glial activation is involved in the protection of IL-10 on maternal E. coli induced neonatal white matter injury. Brain Res Dev Brain Res 157 (2005) 141-149
78. Samuelsson A.M., Jennische E., Hansson H.A., and Holmang A. Prenatal exposure to interleukin-6 results in inflammatory neurodegeneration in hippocampus with NMDA/GABA(A) dysregulation and impaired spatial learning. Am J Physiol Regul Integr Comp Physiol 290 (2006) R1345-R1356
79. Pang Y., Fan L.-W., Zheng B., Cai Z., and Rhodes P.G. Role of interleukin-6 in lipopolysaccharide-induced brain injury and behavioral dysfunction in neonatal rats. Neuroscience 141 (2006) 745-755
80. Bauer S., Kerr B.J., and Patterson P.H. The neuropoietic cytokine family in development, plasticity, disease and injury. Nat Rev Neurosci 8 (2007) 221-232
81. Capuron L., and Dantzer R. Cytokines and depression: the need for a new paradigm. Brain Behav Immun 17 Suppl 1 (2003) S119-S124
82. Theoharides T.C., Weinkauf C., and Conti P. Brain cytokines and neuropsychiatric disorders. J Clin Psychopharmacol 24 (2004) 577-581
83. Schiepers O.J., Wichers M.C., and Maes M. Cytokines and major depression. Prog Neuropsychopharmacol Biol Psychiat 29 (2005) 201-217
84. Libbey J.E., Sweeten T.L., McMahon W.M., and Fujinami R.S. Autistic disorder and viral infections. J Neurovirol 11 (2005) 1-10
85. Curran L.K., Newschaffer C.J., Lee L.C., Crawford S.O., Johnston M.V., and Zimmerman A.W. Behaviors associated with fever in children with autism spectrum disorders. Pediatrics 120 (2007) e1386-e1392
86. Tempelton W.L., and Glas C.B. The effect of malarial fever upon dementia praecox subjects. J Ment Sci 70 (1924) 92-95
87. Hinsie L.E. Malaria treatment of schizophrenia. Psychiatr Q 3 (1929) 210-214
88. Riedel M., Strassnig M., Schwarz M.J., and Muller N. COX-2 inhibitors as adjunctive therapy in schizophrenia. CNS Drugs 19 (2005) 805-819
89. Lowe C.M., Brube R.R.A., and Scates A.C. Characterrization and clinical management of clozapine-induced fever. Ann Pharmacother 41 (2007) 1700-1704
90. Robertson S.A., Skinner R.J., and Care A.S. Essential role for IL-10 in resistance to lipopolysaccharide-induced preterm labor in mice. J Immunol 177 (2006) 4888-4896
91. Meyer U., Murray P.J., Urwyler A., Yee B.K., Schedlowski M., and Feldon J. Adult behavioral and pharmacological dysfunctions following disruption of the fetal brain balance between pro-inflammatory and IL-10-mediated anti-inflammatory signaling. Mol Psychiatry 13 (2008) 208-221
92. Rosenblum I.Y., Johnson R.C., and Schmahai T.J. Preclinical safety evaluation of recombinant human interleukin-10. Regul Toxicol Pharmacol 35 (2002) 56-71
93. Toth F.D., Juhl C., Norskov-Lauritsen N., Petersen P.M., and Ebbesen P. Interferon production by cultured human trophoblast induced with double stranded polyribonucleotide. J Reprod Immunol 17 (1990) 217-227
94. Abrahams V.M., Schaefer T.M., Fahey J.V., Visintin I., Wright J.A., Aldo P.B., et al. Expression and secretion of antiviral factors by trophoblast cells following stimulation by the TLR-3 agonist, Poly(:C). Hum Reprod 21 (2006) 2432-2439
95. Sargent I.L., Borzychowski A.M., and Redman C.W. NK cells and human pregnancy - an inflammatory view. Trends Immunol 27 (2006) 399-404
96. Christiansen O.B., Nielsen H.S., and Kolte A.M. Inflammation and miscarriage. Semin Fetal Neonatal Med 11 (2006) 302-308
97. Arad M., Atzil S., Shakhar K., Adoni A., and Ben-Eliyahu S. Poly I-C induces early embryo loss in f344 rats: a potential role for NK cells. Am J Reprod Immunol 54 (2005) 49-53
98. Martin L.A., Ashwood P., Braunschweig D., Cabanlit M., Van de Water J., and Amaral D.G. Stereotypies and hyperactivity in rhesus monkeys exposed to IgG from mothers of children with autism. Brain Behav Immun 22 (2008) 806-816
99. Kroll J.L. New directions in the conceptualization of psychotic disorders. Curr Opin Psychiatry 20 (2007) 573-577
100. Brown A.S., and Susser E.S. Prenatal nutritional deficiency and risk of adult schizophrenia. Schizophr Bull 34 (2008) 1054-1063
101. Khashan A.S., Abel K.A., McNamee R., Pedersen M.G., Webb R.T., Baker P.N., et al. Higher risk of offspring schizophrenia following antenatal mernal exposure to severe adverse life events. Arch Gen Psychiatry 65 (2008) 146-152
102. Tandon R., Keshavan M.S., and Nasrallah H.A. Schizophrenia, "Just the Facts" what we know in 2008. 2. Epidemiology and etiology. Schizophr Res 102 (2008) 1-18
103. Coe C.L., and Lubach G.R. Prenatal origins of individual variation in behavior and immunity. Neurosci Behav Rev 29 (2005) 39-49
104. Merlot E., Couret D., and Otten W. Prenatal stress, fetal imprinting and immunity. Brain Behav Immun 22 (2008) 42-51
105. Shen Q., Li Z.Q., Sun Y., Wang T., Wan C.L., Li X.W., et al. The role of pro-inflammatory factors in mediating the effects on the fetus of prenatal undernutrition: implications for schizophrenia. Schizophr Res 99 (2008) 48-55
106. Harrison P. The neuropathology of schizophrenia: a critical review of the data and their interpretation. Brain 122 (1999) 593-624
107. Rothermundt M., Arolt V., and Bayer T. Review of immunological and immunopathological findings in schizophrenia. Brain Behav Immun 15 (2001) 319-339
108. Perry V.H., Newman T.A., and Cunningham C. The impact of systemic infection on the progression of neurodegenerative disease. Nat Rev Neurosci 4 (2003) 103-112
109. Cai Z., Pan Z.L., Pang Y., Evans O.B., and Rhodes P.G. Cytokine induction in fetal rat brains and brain injury in neonatal rats after maternal lipopolysaccharide administration. Pediatr Res 47 (2000) 64-72
110. Ling Z., Chang Q.A., Tong C.W., Leurgans S.E., Lipton J.W., and Carvey P.M. Rotenone potentiates dopamine neuron loss in animals exposed to lipopolysaccharide prenatally. Exp Neurol 190 (2004) 373-383
111. Bakos J., Duncko R., Makatsori A., Pirnik Z., Kiss A., and Jezova D. Prenatal immune challenge affects growth, behavior, and brain dopamine in offspring. Ann N Y Acad Sci 1018 (2004) 281-287
112. Fortier M.E., Joober R., Luheshi G.N., and Boksa P. Effects of prenatal infection on prepulse inhibition in the rat depend on the nature of the infectious agent and the stage of pregnancy. Behav Brain Res 181 (2007) 270-277
113. Paintlia M.K., Paintlia A.S., Barbosa E., Singh I., and Singh A.K. N-acetylcysteine prevents endotoxin-induced degeneration of oligodendrocyte progenitors and hypomyelination in developing rat brain. J Neurosci Res 78 (2004) 347-361
114. Golan H.M., Lev V., Hallak M., Sorokin Y., and Huleihel M. Specific neurodevelopmental damage in mice offspring following maternal inflammation during pregnancy. Neuropharmacololgy 48 (2005) 903-917
115. Golan H., Stilman M., Lev V., and Huleihel M. Normal aging of offspring mice of mothers with induced inflammation during pregnancy. Neuroscience 141 (2006) 1909-1918
116. Lee KH, Smith SEP, Kim S, Patterson PH, Thompson RF. Matrnal immune activation impairs extinction of the conditioned eye blink response in the adult offspring. Program No. 209.4. 2007 Neuroscience Meeting Planner. San Diego, CA: Soc for Neurosci; 2007 [online].
117. Urakubo A., Jarskog L.F., Lieberman J.A., and Gilmore J.H. Prenatal exposure to maternal infection alters cytokine expression in the placenta, amniotic fluid, and fetal brain. Schizophr Res 47 (2001) 27-36
118. Ashdown H., Dumont Y., Ng M., Poole S., Boksa P., and Luheshi G.N. The role of cytokines in mediating effects of prenatal infection on the fetus: implications for schizophrenia. Mol Psychiatry 11 (2006) 47-55
119. Liverman C.S., Kaftan H.A., Cui L., Hersperger S.G., Taboada E., Klein R.M., and Berman N.E. Altered expression of pro-inflammatory and developmental genes in the fetal brain in a mouse model of maternal infection. Neurosci Lett 399 (2006) 220-225
120. Samland H., Huitron-Resendiz S., Masliah E., Criado J., Henriksen S.J., and Campbell I.L. Profound increase in sensitivity to glutamatergic- but not cholinergic agonist-induced seizures in transgenic mice with astrocyte production of IL-6. J Neurosci Res 73 (2003) 176-187
121. Boris M., Kaiser C.C., Goldblatt A., Elice M.W., Edelson S.M., Adams J.B., and Feinstein D.L. Effect of pioglitazone treatment on behavioral symptoms in autistic children. J Neuroinflammation 4 (2007) 3
122. Stolk P., Souverein P.C., Leufkens H.G., Weil J.G., Egberts A.C., and Heerdink E.R. The exposure to COX-2 inhibitors and schizophrenia deterioration. A nested case-control study. Pharmacopsychiatry 40 (2007) 111-115
123. Dalton P., Deacon R., Blamire A., Pike M., McKinaly I., Stein J., Syyles P., and Vicent A. Maternal neuronal antibodies associated with autism and a language disorder. Ann Neurol 53 (2003) 533-537